Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market 2026–2030: Emerging Trends and Forecast Opportunities
Uncover key drivers, emerging technologies, and competitive movements shaping the cell and gene therapy contract development and manufacturing organization (cdmo) market from 2026–2035 with trusted insights from The Business Research Company
How is the Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market size predicted to change over the forecast window of 2026–2035?
The cell and gene therapy contract development and manufacturing organization (CDMO) market size has experienced significant expansion in recent years. This market is projected to grow from $6.92 billion in 2025 to $8.85 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 27.8%. The historical growth of this market can be attributed to factors such as increasing outsourcing of advanced therapy manufacturing, constraints in in-house development capabilities, the emergence of early-stage biotech companies, the widening scope of orphan drug development, and a heightened demand for specialized expertise.
The cell and gene therapy contract development and manufacturing organization (cdmo) market is set for substantial growth over the next few years, with projections indicating it will reach $21.35 billion by 2030, expanding at a compound annual growth rate (CAGR) of 24.6%. This anticipated expansion is primarily driven by the increasing commercialization of gene-modified therapies, a heightened need for adaptable manufacturing capacity, the broadening of global cdmo collaborations, escalating investment in cell therapy pipelines, and a rise in regulatory approvals for advanced therapies. Key trends during this period are expected to include the broadening of end-to-end cdmo service offerings, growing demand for large-scale manufacturing support, increased adoption of advanced gene editing platforms, a stronger focus on accelerated development timelines, and the improved integration of regulatory support services.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15753&type=smp
Which Drivers Are Contributing To The Expansion Of The Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market?
The rising occurrence of cancer is anticipated to drive the expansion of the cell and gene therapy contract development and manufacturing organization (CDMO) market moving forward. Cancer refers to a collection of diseases characterized by the unregulated multiplication and spread of anomalous cells throughout the body. The increasing number of cancer diagnoses is attributable to an aging population, evolving lifestyles, environmental exposures, and advancements in detection methods. The cell and gene therapy contract development and manufacturing organization (CDMO) contributes to mitigating cancer prevalence by developing and producing innovative, targeted therapies that enhance both efficacy and patient outcomes. For instance, in July 2024, figures from the Australian Institute of Health and Welfare, an Australia-based government agency, showed that in 2023, an estimated 165,000 Australians were newly diagnosed with cancer, which is equivalent to more than 450 cases per day, and approximately 55% of these diagnoses were among males. Thus, the growing prevalence of cancer cases acts as a key driver for the growth of the cell and gene therapy contract development and manufacturing organization (CDMO) market.
What Segment Categories Are Covered In The Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market?
The cell and gene therapy contract development and manufacturing organization (cdmo) market covered in this report is segmented –
1) By Product Type: Gene Therapy, Gene-Modified Cell Therapy, Cell Therapy
2) By Phase: Phase 1, Phase 2, Phase 3
3) By Indication: Oncology, Infectious Diseases, Neurological Disorders, Rare Diseases, Other Indications
Subsegments:
1) By Gene Therapy: Viral Vector-Based Gene Therapy, Non-Viral Gene Therapy, Plasmid DNA-Based Gene Therapy
2) By Gene-Modified Cell Therapy: CAR-T Cell Therapy, TCR-T Cell Therapy, NK Cell Therapy
3) By Cell Therapy: Stem Cell Therapy, Progenitor Cell Therapy, Immune Cell Therapy
What Trends Are Reshaping The Dynamics Of The Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market?
Companies operating prominently in the cell and gene therapy contract development and manufacturing organization (CDMO) market are prioritizing the expansion of their offerings with innovative solutions like PluriMatrix technology, aimed at improving the scalability, efficiency, and quality of producing cell-based products. PluriMatrix technology is a proprietary system specifically designed for the large-scale production of cell-based products. This advanced technology enables the industrial-scale 3D expansion of cells, ensuring high yield and consistent quality through an automated, fully controlled, and validated process. For instance, in January 2024, Pluri, an Israel-based biotech company, launched PluriCDMO, a new business division offering cell therapy manufacturing services as a contract development and manufacturing organization (CDMO). The new division incorporates a 47,000-square-foot good manufacturing practice (GMP) cell therapy production facility. Pluri’s recently established division provides comprehensive services, from early preclinical stages to late-stage clinical trials and commercialization, encompassing process and analytical development, scale-up, validation, logistics, automation, and regulatory-approved comparability studies, as outlined in a company announcement. It utilizes the company’s cutting-edge PluriMatrix technology to deliver advanced cell therapy manufacturing services.
Which Leading Companies Dominate The Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Share?
Major companies operating in the cell and gene therapy contract development and manufacturing organization (cdmo) market are Lonza Group, Catalent Inc, Thermo Fisher Scientific Inc, Samsung Biologics Co Ltd, WuXi Biologics, AGC Biologics, FUJIFILM Diosynth Biotechnologies, Oxford BioMedica Plc, Recipharm AB, Almac Group Ltd, KBI Biopharma, Rentschler Biopharma, Avid Bioservices Inc, Charles River Laboratories International Inc, VGXI Inc, Genezen Laboratories Inc, OmniaBio Inc, Pluri Inc, Cell and Gene Therapy Catapult, BioVectra Inc, Porton Advanced Solutions Ltd
Access The Complete Report For Deeper Market Insights:
How Does The Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Perform Across Major Global Regions?
North America was the largest region in the cell and gene therapy contract development and manufacturing organization (CDMO) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell and gene therapy contract development and manufacturing organization (cdmo) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=15753&type=smp
Browse Through More Reports Similar to the Global Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market 2026, By The Business Research Company
Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization Cdmo Market Report 2026
Cell And Gene Therapy Manufacturing Services Market 2026
Cell And Gene Therapy Supply Chain Or Logistics Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
